One way to simultaneously improve blood sugar, body weight, and overall metabolic health is the development and use of dual and triple agonists
However, the reduction in HF hospitalisations with semaglutide did not reach statistical significance
Sign up to all DiabetesontheNet journals By clicking Subscribe, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters
GLP-1 receptors in the brain The brain contains abundant GLP-1 receptors in key regions including the hippocampus, cerebral cortex, hypothalamus, thalamus, and globus pallidum 26
The development could reshape the fast-growing market for GLP-1 medicines, which were developed to manage type 2 diabetes but have attracted worldwide demand because of their ability to support significant weight loss
They may also help mitigate mild gastrointestinal side effects